Browse Studies — Arctuva

Phase 2

NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury (NACAM) Trial

A Randomized, Double-blind, placebo-controlled Trial to Evaluate the Efficacy of Oral Nam for the Prevention of Acute Kidney Injury in Patients Undergoing On-P…

Ischemia Reperfusion InjuryMyocardial InjuryAcute Kidney Injury

Estimated

~$10 – $7,500

Kaiser PermanenteNCT04750616

Observational

Light Utilization COX-Inhibitory Device Therapy for Infant Cardiac Arrest (LUTICA Study)

Approximately 15,200 children receive cardiopulmonary resuscitation (CPR) for in-hospital cardiac arrest (IHCA) each year in the United States. Of these, about…

Reperfusion InjuryPost Cardiac Arrest Brain Injury

Estimated

~$10 – $8,750

Mitovation, IncNCT07556939

Phase 1

A Phase I/II Study Evaluating the Preliminary Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During De Novo Adult Kidney Transplantation

The objectives of this study are to test the preliminary safety and efficacy of a two-day peri-operative course of treprostinil in reducing ischemia-reperfusio…

Ischemia Reperfusion InjuryDelayed Graft Function

Estimated

~$10 – $6,250

Rhode Island HospitalNCT04005469

Phase 1

Hydrogen's Feasibility and Safety as a Therapy in Extracorporeal Cardiopulmonary Resuscitation

The purpose of this project is to test the feasibility and safety of inhaled hydrogen gas (H2) administration as a rescue therapy during cardiac arrest requiri…

Cardiac ArrestExtracorporeal Membrane OxygenationReperfusion Injury

Estimated

~$10 – $6,250

Boston Children's HospitalNCT05574296